All In Biotech

Drug Trial Radar · NCT00483652

Study of Fampridine-SR Tablets in Multiple Sclerosis Patients

Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR (10 mg b.i.d. [Bis in Die, Twice Daily]) in Patients With Multiple Sclerosis

Last checked: Nov 20, 2026Latest source record: Feb 4, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 240 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

240

Actual

Start

May 2007

Primary completion

Feb 2008

Study completion May 2008

Sponsor

Lead sponsor
Acorda TherapeuticsIndustry
Sponsor type
Industry
First posted
Jun 7, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to show that individuals treated with Fampridine-SR tablets are significantly more likely to have consistent improvements in their walking than those treated with placebo tablets.

Conditions

  • Multiple Sclerosis

Interventions

  • Fampridine-SRDrug

    Tablets, 10 mg, twice daily, 9 weeks

  • PlaceboDrug

    placebo (sugar pill)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Responders Based Upon the Timed 25-Foot Walk [T25FW]Time frame: Days -21, -14, -7, 0, 14, 28, 42, 56, 63, 77

Locations

40 sites in 2 countries. Site status is shown where the registry gives one.

  • Barrow Neurology Clinic, St. Joseph's Hospital and Medical Center

    Phoenix, Arizona

  • HOPE Research Institute

    Phoenix, Arizona

  • Neurological Associates

    Fayetteville, Arkansas

  • Alta Bates Summit Medical Center - Research and Education Institute

    Berkeley, California

  • USC, Keck School of Medicine Health Care Consultation Center

    Los Angeles, California

  • UC Davis

    Sacramento, California

  • Yale University MS Center

    New Haven, Connecticut

  • Shepherd Center

    Atlanta, Georgia

  • Consultants in Neurology, Ltd.

    Northbrook, Illinois

  • Indiana University MS Center

    Indianapolis, Indiana

  • Associates in Neurology, PSC

    Lexington, Kentucky

  • Maryland Center for MS

    Baltimore, Maryland

  • Lahey Clinic

    Lexington, Massachusetts

  • The Schapiro Center for MS

    Golden Valley, Minnesota

  • Washington University School of Medicine

    St Louis, Missouri

  • Advanced Neurology Specialists

    Great Falls, Montana

  • UMDNJ

    Newark, New Jersey

  • Gimbel MS Center at Holy Name Hospital

    Teaneck, New Jersey

  • Jacobs Neurological Institute Buffalo General Hospital

    Buffalo, New York

  • Corinne Goldsmith Dickinson Center for MS

    New York, New York

  • Columbia University Multiple Sclerosis Clinical Care Center

    New York, New York

  • University of Rochester

    Rochester, New York

  • SUNY Stony Brook

    Stony Brook, New York

  • CMC - Neuroscience & Spine Institute, Division of Neurology

    Charlotte, North Carolina

  • Raleigh Neurology Associates

    Raleigh, North Carolina

  • Wake Forest University, Dept of Neurology, M.S. Research

    Winston-Salem, North Carolina

  • The Center for Neurological Services

    Bismarck, North Dakota

  • Cleveland Clinic Foundation

    Cleveland, Ohio

  • Ohio State University MS Center

    Columbus, Ohio

  • Oregon Health & Science University, MS Center of Oregon, UHS-42

    Portland, Oregon

  • Thomas Jefferson University Physicians

    Philadelphia, Pennsylvania

  • Neurological Research Center, Inc.

    Bennington, Vermont

  • Fletcher Allen Health Care

    Burlington, Vermont

  • MS Center at Evergreen

    Kirkland, Washington

  • CAMC Health Education & Research Institute

    Charleston, West Virginia

  • Center for Neurological Disorders of Aurora, St. Luke's Medical Center

    Milwaukee, Wisconsin

  • Foothills Medical Center

    Calgary, Alberta, Canada

  • University of British Columbia, Vancouver Coastal Health Research Institute

    Vancouver, British Columbia, Canada

  • River Valley Health c/o Stan Cassidy Centre for Rehabilitation

    Fredericton, New Brunswick, Canada

  • QEII Health Sciences Centre, Nova Scotia Rehabilitation Centre Site

    Halifax, Nova Scotia, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.